why choose us

First received: June 16, 2023

Clinical Trial: A Phase I Study to Investigate the Effect of Hepatic Impairment on the PK, Safety, and Tolerability of AZD2693

Study Status: Completed

Recruit Status: RECRUITING

Condition: Hepatic Impairment

Study Type: INTERVENTIONAL


Official Title: A Single Dose, Non-Randomised, Open-Label, Parallel Group Study to Investigate the Effect of Hepatic Impairment on the Pharmacokinetics, Safety and Tolerability of AZD2693

Brief Summary: Subcutaneous administration of AZD2693 single dose in participants with hepatic impairment

Read more